↓ Skip to main content

Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA: A Dual-Center Retrospective Observational Study

Overview of attention for article published in Frontiers in Neurology, May 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

news
1 news outlet
twitter
2 X users

Citations

dimensions_citation
70 Dimensions

Readers on

mendeley
48 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA: A Dual-Center Retrospective Observational Study
Published in
Frontiers in Neurology, May 2020
DOI 10.3389/fneur.2020.00417
Pubmed ID
Authors

Bianca Raffaelli, Rea Kalantzis, Jasper Mecklenburg, Lucas Hendrik Overeem, Lars Neeb, Astrid Gendolla, Uwe Reuter

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 48 100%

Demographic breakdown

Readers by professional status Count As %
Other 10 21%
Researcher 6 13%
Student > Bachelor 5 10%
Student > Master 4 8%
Student > Ph. D. Student 3 6%
Other 3 6%
Unknown 17 35%
Readers by discipline Count As %
Neuroscience 9 19%
Medicine and Dentistry 9 19%
Pharmacology, Toxicology and Pharmaceutical Science 4 8%
Biochemistry, Genetics and Molecular Biology 3 6%
Nursing and Health Professions 2 4%
Other 1 2%
Unknown 20 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 May 2020.
All research outputs
#2,988,029
of 23,211,181 outputs
Outputs from Frontiers in Neurology
#2,057
of 12,134 outputs
Outputs of similar age
#79,257
of 395,701 outputs
Outputs of similar age from Frontiers in Neurology
#187
of 393 outputs
Altmetric has tracked 23,211,181 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,134 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 395,701 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 393 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.